Cronos Group publishes results of the second quarter of 2025

Cronos Group Inc. (Nasdaq: Cron) is among the 12 best marijuana actions to buy according to analysts. Cronos Group Inc. (Nasdaq: Cron) announced $ 33.5 million in net revenue for the second quarter of 2025, a leap of 21% from one year to the next. Growth was due to the booming sales of cannabis flowers in Israel and international markets, the consolidation of Cronos Growco and sales of stronger Canadian extracts. The gross profit increased from $ 8.2 million in the second quarter from 2024 to 14.5 million dollars. The adjusted Baiia increased from $ 12.7 million in the previous year to $ 1.7 million. Cronos declared a net loss of $ 38.5 million despite the advantages of sales growth and efficiency.
Cronos Group Inc.’s Peace Naturals® (Nasdaq: Cron) has retained its position from the main cannabis brand of Israel, leading record sales in the country. CEO Mike Gorenstein has noted planned growth in the capacity of flowers and high global momentum to mitigate supply limitations in Canada. The sales of flowers of this quarter reported approximately $ 2.2 million for Cronos Growco. The company maintains a solid assessment with 834 million dollars in cash and without debt, which allows it to support international growth and innovation in brands such as Lord Jones® and Spinach®. This is one of Best marijuana stocks.
Although we recognize Cron’s potential as an investment, we believe that certain AI actions offer greater increase in increase and have a less unknown risk. If you are looking for an extremely undervalued AI stock that should also benefit considerably from the Trump era tariffs and the excessive trend, see our free report on the Best short -term AI stock.
Read then: 10 EV shares with high growth to invest And 13 Best car actions to buy in 2025.
Disclosure. None.



